Abstracts (HTML) List of Authors

Balasubrama, GP

Molecular Characterization of Radiation-induced Glioblastoma

Bartholomä, S

Combination therapy as a potential strategy in Glioblastoma treatment

Buljovcic, K

Combination therapy as a potential strategy in Glioblastoma treatment

Classen, CF

Malignancy-promoting EGFR overexpression in glioblastoma: in vitro inhibitor susceptibility and establishment of an in vivo model

Debatin, KM

Combination therapy as a potential strategy in Glioblastoma treatment

Deimling, A von

Molecular Characterization of Radiation-induced Glioblastoma

Deng, MY

Molecular Characterization of Radiation-induced Glioblastoma

Dwucet, A

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Ebinger, M

Molecular Characterization of Radiation-induced Glioblastoma
Deciphering the AT/RT ligandome

Engelke, J

Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Erdlenbruch, B

Editorial

Eyrich, M

Deciphering the AT/RT ligandome

Feyen, O

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice
Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Fiedler, L

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice

Frühwald, M

Deciphering the AT/RT ligandome

Gaunitz, F

Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival

Glasow, A

Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival

Gutmann, F

Malignancy-promoting EGFR overexpression in glioblastoma: in vitro inhibitor susceptibility and establishment of an in vivo model

Halatsch, ME

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combination therapy as a potential strategy in Glioblastoma treatment
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Henkel, L

Deciphering the AT/RT ligandome

Hlavac, M

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Johann, P

Deciphering the AT/RT ligandome

Jones, DTW

Molecular Characterization of Radiation-induced Glioblastoma

Karpel-Massler, G

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combination therapy as a potential strategy in Glioblastoma treatment
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Kast, RE

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Kattner, P

Combination therapy as a potential strategy in Glioblastoma treatment

Kim, EL

Integrated approach to delineating molecular traits of recurrent glioblastoma using glioma stem cell models and tumor tissue profiling

Korshunov, A

Molecular Characterization of Radiation-induced Glioblastoma

Kortmann, RD

Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival

Krauß, J

Deciphering the AT/RT ligandome

Lager, J

Deciphering the AT/RT ligandome

Machova, A

Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Makalowski, J

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice
Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Marcu, A

Deciphering the AT/RT ligandome

Monoranu, C

Deciphering the AT/RT ligandome

Nonnenmacher, L

Combination therapy as a potential strategy in Glioblastoma treatment

Oyen, F

Deciphering the AT/RT ligandome

Patties, I

Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival

Pfaff, E

Molecular Characterization of Radiation-induced Glioblastoma

Pfister, SM

Molecular Characterization of Radiation-induced Glioblastoma

Pietsch, T

Deciphering the AT/RT ligandome

Prix, L

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice

Rammensee, HG

Deciphering the AT/RT ligandome

Reisner, Y

Deciphering the AT/RT ligandome

Schierl, R

Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Schirrmacher, V

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice
Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Schittenhelm, J

Molecular Characterization of Radiation-induced Glioblastoma

Schlegel, PG

Deciphering the AT/RT ligandome

Schuhmann, M

Molecular Characterization of Radiation-induced Glioblastoma
Deciphering the AT/RT ligandome

Siegelin, MD

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Stevanovic, S

Deciphering the AT/RT ligandome

Stuecker, W

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice
Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Sturm, D

Molecular Characterization of Radiation-induced Glioblastoma

Technau, A

Deciphering the AT/RT ligandome

Thöle, L

Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival

Thomale, U

Deciphering the AT/RT ligandome

Trautwein, N

Deciphering the AT/RT ligandome

Van Gool, SW

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice
Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia

Westhoff, A

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Westhoff, MA

Combination therapy as a potential strategy in Glioblastoma treatment

Wirtz, CR

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing
Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma

Witt, O

Molecular Characterization of Radiation-induced Glioblastoma

Wölfl, M

Deciphering the AT/RT ligandome

Zeiler, K

Combination therapy as a potential strategy in Glioblastoma treatment